Interventions for cutaneous molluscum contagiosum
- PMID: 16625612
- DOI: 10.1002/14651858.CD004767.pub2
Interventions for cutaneous molluscum contagiosum
Update in
-
Interventions for cutaneous molluscum contagiosum.Cochrane Database Syst Rev. 2009 Oct 7;(4):CD004767. doi: 10.1002/14651858.CD004767.pub3. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2017 May 17;5:CD004767. doi: 10.1002/14651858.CD004767.pub4. PMID: 19821333 Updated.
Abstract
Background: Molluscum contagiosum is a common skin infection, caused by a virus, which will usually resolve within months in people with a normal immune system. Many treatments have been promoted for molluscum contagiosum but a clear evidence base supporting them is lacking.
Objectives: To assess the effects of management strategies (including waiting for natural resolution) for cutaneous, non-genital molluscum contagiosum in healthy people.
Search strategy: We searched the Skin Group Specialised Register (March 2004), the Cochrane Central Register of Controlled Trials (2004, Issue 2), MEDLINE (from 1966 to March 2004), EMBASE (from 1980 to March 2004) and LILACS (from 1982 to March 2004) databases. We also searched reference lists and contacted pharmaceutical companies and experts in the field.
Selection criteria: Randomised controlled trials for treatment of molluscum contagiosum were investigated. Trials on sexually transmitted molluscum contagiosum and in people with lowered immunity (including those with HIV infection) were excluded.
Data collection and analysis: Study selection and assessment of methodological quality were carried out by two independent authors. As similar comparisons between two interventions were not made in more than one study, statistical pooling was not performed.
Main results: Five studies, with a total number of 137 participants, examined the effects of topical (three studies), systemic and homoeopathic interventions (one study each). Limited evidence was found for sodium nitrite co-applied with salicylic acid compared to salicylic acid alone (risk ratio (RR) 3.50, 95% confidence interval (CI) 1.23 to 9.92). No statistically significant differences were found for topical povidone iodine plus salicylic acid compared to povidone iodine alone (RR of cure 1.67, 95% CI 0.81 to 3.41) or compared to salicylic acid alone. Also no statistically significant differences were found for potassium hydroxide compared to placebo; systemic treatment with cimetidine versus placebo or systemic treatment with calcarea carbonica, a homoeopathic drug, versus placebo (RR 5.57, 95% CI 0.93 to 33.54). Study limitations included no blinding (two studies), many dropouts (three studies) and no intention-to-treat analysis (two studies); small study sizes may have led to important differences being missed. None of the evaluated treatment options were associated with serious adverse effects.
Authors' conclusions: No single intervention has been shown to be convincingly effective in treating molluscum contagiosum.
Similar articles
-
Interventions for cutaneous molluscum contagiosum.Cochrane Database Syst Rev. 2017 May 17;5(5):CD004767. doi: 10.1002/14651858.CD004767.pub4. Cochrane Database Syst Rev. 2017. PMID: 28513067 Free PMC article.
-
Interventions for cutaneous molluscum contagiosum.Cochrane Database Syst Rev. 2009 Oct 7;(4):CD004767. doi: 10.1002/14651858.CD004767.pub3. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2017 May 17;5:CD004767. doi: 10.1002/14651858.CD004767.pub4. PMID: 19821333 Updated.
-
Interventions for infantile haemangiomas of the skin.Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD006545. doi: 10.1002/14651858.CD006545.pub3. Cochrane Database Syst Rev. 2018. PMID: 29667726 Free PMC article.
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
-
Control interventions in randomised trials among people with mental health disorders.Cochrane Database Syst Rev. 2022 Apr 4;4(4):MR000050. doi: 10.1002/14651858.MR000050.pub2. Cochrane Database Syst Rev. 2022. PMID: 35377466 Free PMC article.
Cited by
-
Improving Molluscum Treatment Options: Overcoming the Challenge of Poor Adherence.J Clin Aesthet Dermatol. 2025 Jul 1;18(7):12-16. J Clin Aesthet Dermatol. 2025. PMID: 40778008 Free PMC article. Review.
-
Molluscum contagiosum: an update and review of new perspectives in etiology, diagnosis, and treatment.Clin Cosmet Investig Dermatol. 2019 May 30;12:373-381. doi: 10.2147/CCID.S187224. eCollection 2019. Clin Cosmet Investig Dermatol. 2019. PMID: 31239742 Free PMC article. Review.
-
New Developing Treatments for Molluscum Contagiosum.Dermatol Ther (Heidelb). 2022 Dec;12(12):2669-2678. doi: 10.1007/s13555-022-00826-7. Epub 2022 Oct 14. Dermatol Ther (Heidelb). 2022. PMID: 36239905 Free PMC article. Review.
-
Interventions for cutaneous molluscum contagiosum.Cochrane Database Syst Rev. 2017 May 17;5(5):CD004767. doi: 10.1002/14651858.CD004767.pub4. Cochrane Database Syst Rev. 2017. PMID: 28513067 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials